BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 33104837)

  • 21. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
    He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
    Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CMTM6, a potential immunotherapy target.
    Liang J; Li S; Li W; Rao W; Xu S; Meng H; Zhu F; Zhai D; Cui M; Xu D; Cai J; Zhang B
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):47-56. PubMed ID: 34783871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment.
    Zhang T; Yu H; Dai X; Zhang X
    Front Immunol; 2022; 13():971428. PubMed ID: 35958549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triptolide suppresses oral cancer cell PD-L1 expression in the interferon-γ-modulated microenvironment in vitro, in vivo, and in clinical patients.
    Kuo CS; Yang CY; Lin CK; Lin GJ; Sytwu HK; Chen YW
    Biomed Pharmacother; 2021 Jan; 133():111057. PubMed ID: 33378962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of HMGB1 inhibits the crosstalk between oral squamous cell carcinoma cells and tumor-associated macrophages.
    Wen J; Yin P; Su Y; Gao F; Wu Y; Zhang W; Chi P; Chen J; Zhang X
    Int Immunopharmacol; 2023 Jun; 119():110259. PubMed ID: 37141670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. lncRNA DCST1-AS1 Facilitates Oral Squamous Cell Carcinoma by Promoting M2 Macrophage Polarization through Activating NF-
    Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Zou C
    J Immunol Res; 2021; 2021():5524231. PubMed ID: 34414241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of CD168 is related to poor prognosis in oral squamous cell carcinoma.
    Zhu SW; Wang S; Wu ZZ; Yang QC; Chen DR; Wan SC; Sun ZJ
    Oral Dis; 2022 Mar; 28(2):364-372. PubMed ID: 33386685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Periodontitis Promotes the Progression of Oral Squamous Cell Carcinoma by Inducing Macrophage M2 Polarization].
    Li J; Wei W; Tang BY; Li Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):83-90. PubMed ID: 36647648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of CXCL2-mediated crosstalk between tumor cells and macrophages in Fusobacterium nucleatum-promoted oral squamous cell carcinoma progression.
    Nie F; Zhang J; Tian H; Zhao J; Gong P; Wang H; Wang S; Yang P; Yang C
    Cell Death Dis; 2024 Apr; 15(4):277. PubMed ID: 38637499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RCN1 deficiency inhibits oral squamous cell carcinoma progression and THP-1 macrophage M2 polarization.
    Liu H; Guo H; Wu Y; Hu Q; Hu G; He H; Yin Y; Nan X; Lin G; Han J; Zhao R; Liu Y
    Sci Rep; 2023 Dec; 13(1):21488. PubMed ID: 38057406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage-Derived Exosomal miR-31-5p Promotes Oral Squamous Cell Carcinoma Tumourigenesis Through the Large Tumor Suppressor 2-Mediated Hippo Signalling Pathway.
    Yuan Y; Wang Z; Chen M; Jing Y; Shu W; Xie Z; Li Z; Xu J; He F; Jiao P; Wang J; Xu J; Xia Y; Liu S; Du H; Li H; Dai L; Dai Y; Zhang Y
    J Biomed Nanotechnol; 2021 May; 17(5):822-837. PubMed ID: 34082869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxic lung cancer cell-derived exosomal miR-21 mediates macrophage M2 polarization and promotes cancer cell proliferation through targeting IRF1.
    Jin J; Yu G
    World J Surg Oncol; 2022 Jul; 20(1):241. PubMed ID: 35897096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer‑associated fibroblast‑derived exosomal miR‑382‑5p promotes the migration and invasion of oral squamous cell carcinoma.
    Sun LP; Xu K; Cui J; Yuan DY; Zou B; Li J; Liu JL; Li KY; Meng Z; Zhang B
    Oncol Rep; 2019 Oct; 42(4):1319-1328. PubMed ID: 31364748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 35. CMTM6 Stabilizes PD-L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma.
    Yugawa K; Itoh S; Yoshizumi T; Iseda N; Tomiyama T; Morinaga A; Toshima T; Harada N; Kohashi K; Oda Y; Mori M
    Hepatol Commun; 2021 Feb; 5(2):334-348. PubMed ID: 33553979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CMTM6: increased circulating level and up-regulated expression in labial salivary glands in patients with primary Sjogren's syndrome.
    Qian S; Xu J; Zhao S; Yang P; Yang C
    Clin Exp Immunol; 2022 Jan; 207(1):65-71. PubMed ID: 35020842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting CMTM6 Suppresses Stem Cell-Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma.
    Chen L; Yang QC; Li YC; Yang LL; Liu JF; Li H; Xiao Y; Bu LL; Zhang WF; Sun ZJ
    Cancer Immunol Res; 2020 Feb; 8(2):179-191. PubMed ID: 31771985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lectin-like Transcript-1 (LLT1) Expression in Oral Squamous Cell Carcinomas: Prognostic Significance and Relationship with the Tumor Immune Microenvironment.
    de Vicente JC; Lequerica-Fernández P; Rodrigo JP; Rodríguez-Santamarta T; Blanco-Lorenzo V; Prieto-Fernández L; Corte-Torres D; Vallina A; Domínguez-Iglesias F; Álvarez-Teijeiro S; García-Pedrero JM
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential Expression of CKLF-like MARVEL Transmembrane Domain-Containing Protein 6 and Programmed Cell Death Ligand 1 as Prognostic Biomarkers in Upper Tract Urothelial Carcinoma.
    Kdimati S; Christoph C; Glass Ä; Engel N; Dräger DL; Maletzki C; Becker AS; Zimpfer A
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor Cell-Derived Exosomal miR-191-5p Activates M2-Subtype Macrophages Through SOCS3 to Facilitate Breast Cancer.
    Ni J; Xi X; Xiao S; Xiao X
    Mol Biotechnol; 2024 May; 66(5):1314-1325. PubMed ID: 38270757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.